Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: firstname.lastname@example.org. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Abbreviations used in this report
|ACIP||Advisory Committee on Immunization Practices|
|ap||acellular pertussis vaccine (without tetanus and diphtheria toxoids)|
|B. bronchiseptica||Bordetella bronchiseptica|
|B. holmesii||Bordetella holmesii|
|B. parapertussis||Bordetella parapertussis|
|B. pertussis||Bordetella pertussis|
|C. diphtheriae||Corynebacterium diphtheriae|
|C. tetani||Clostridium tetani|
|C. ulcerans||Corynebacterium ulcerans|
|CSTE||Council of State and Territorial Epidemiologists|
|DFA||direct fluorescent antibody|
|DT||pediatric diphtheria and tetanus toxoids vaccine|
|DTaP||pediatric diphtheria and tetanus toxoids and acellular pertussis vaccine|
|DTP||pediatric diphtheria and tetanus toxoids and whole cell pertussis vaccine|
|ELISA||enzyme-linked immunosorbent assay|
|ELS||extensive limb swelling|
|FDA||Food and Drug Administration|
|GMC||geometric mean antibody concentration|
|GMT||geometric mean titer|
|HIV||human immunodeficiency virus|
|IOM||Institute of Medicine|
|Lf||limit of flocculation unit|
|MCV4||tetravalent meningococcal conjugate vaccine|
|MDPH||Massachusetts Department of Public Health|
|MPHBL||Massachusetts Public Health Biologic Laboratories|
|NNDSS||National Notifiable Diseases Surveillance System|
|NHANES||National Health and Nutritional Examination Survey|
|PCR||polymerase chain reaction|
|PPD||tuberculin purified protein derivative|
|QALY||quality adjusted life year|
|SAE||serious adverse event|
|SPSS||Supplemental Pertussis Surveillance System|
|Tdap||tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine|
|Td||adult tetanus and diphtheria toxoids vaccine|
|TIG||tetanus immune globulin|
|TIV||trivalent inactivated influenza vaccine|
|TT||tetanus toxoid vaccine|
|VAERS||Vaccine Adverse Event Reporting System|
|VICP||Vaccine Injury Compensation Program|
Advisory Committee on Immunization Practices Pertussis Working Group
Chair: Jon Abramson, MD, Winston-Salem, North Carolina.
Members: Guthrie Birkhead, MD, Albany, New York; Karen Broder, MD, Atlanta, Georgia; Dennis Brooks, MD, Baltimore, Maryland; Angela Calugar, MD, Atlanta, Georgia; Richard Clover, MD, Louisville, Kentucky; James Cheek, MD, Albuquerque, New Mexico; Margaret Cortese, MD, Atlanta, Georgia; Shelly Deeks, MD, Toronto, Ontario, Canada; Lorraine Duncan, Portland, Oregon; Geoffrey Evans, MD, Rockville, Maryland; Theresa Finn, PhD, Rockville, Maryland; Stanley Gall, MD, Louisville, Kentucky; Steve Gordon, MD, Cleveland, Ohio; Janet Gilsdorf, MD, Ann Arbor, Michigan; John Iskander, MD, Atlanta, Georgia; David Klein, PhD, Bethesda, Maryland; Katrina Kretsinger, MD, Atlanta, Georgia; Susan Lett, MD, Boston, Massachusetts; Sara Long, MD, Philadelphia, Pennsylvania; Bruce Meade, PhD, Rockville, Maryland; Julie Morita, MD, Chicago, Illinois; Trudy Murphy, MD, Atlanta, Georgia; Stephen Phillips, DO, Falls Church, Virginia; Margaret Rennels, MD, Baltimore, Maryland; Robert Scalettar, MD, North Haven, Connecticut; William Schaffner, MD, Nashville, Tennessee; Ann Schwartz, MD, Rockville Maryland; Barbara Slade, MD, Atlanta, Georgia; Tejpratap Tiwari, MD, Atlanta, Georgia; Gregory Wallace, MD, Atlanta, Georgia.
Advisory Committee on Immunization Practices
Membership List, June 2005
Chairman: Myron J. Levin, MD, University of Colorado Health Sciences Center, Denver, Colorado.
Executive Secretary: Larry K. Pickering, MD, Senior Advisor to the Director, National Immunization Program, CDC, Atlanta, Georgia.
Members: Jon S. Abramson, MD, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Ban Mishu Allos, MD, Vanderbilt University School of Medicine, Nashville, Tennessee; Guthrie S. Birkhead, MD, New York State Department of Health, Albany, New York; Judith Campbell, MD, Baylor College of Medicine, Houston, Texas; Reginald Finger, MD, Focus on the Family, Colorado Springs, Colorado; Janet R. Gilsdorf, MD, University of Michigan, Ann Arbor, Michigan; Tracy Lieu, MD, Harvard Pilgram Healthcare and Harvard Medical School, Boston, Massachusetts; Edgar K. Marcuse, MD, Children's Hospital and Regional Medical Center, Seattle, Washington; Julie Morita, MD, Chicago Department of Public Health, Chicago, Illinois; Gregory A. Poland, MD, Mayo Medical School, Rochester, Minnesota; John B. Salamone, National Italian American Foundation, Washington, D.C.; Patricia, Stinchfield, MS, Children's Hospitals and Clinics, St. Paul, Minnesota; John J. Treanor, MD, University of Rochester School of Medicine and Dentistry, Rochester, New York; and Robin J. Womeodu, MD, University of Tennessee Health Sciences Center, Memphis, Tennessee.
Ex-Officio Members: James E. Cheek, MD, Indian Health Service, Albuquerque, New Mexico; Wayne Hachey, DO, Department of Defense, Falls Church, Virginia; Geoffrey S. Evans, MD, Health Resources and Services Administration, Rockville, Maryland; Bruce Gellin, MD, National Vaccine Program Office, Washington, DC; Linda Murphy, Centers for Medicare and Medicaid Services, Baltimore, Maryland; George T. Curlin, MD, National Institutes of Health, Bethesda, Maryland; Norman Baylor, PhD, Office of Vaccines Research Review, Rockville, Maryland; Kristin Lee Nichol, MD, Department of Veterans Affairs, Minneapolis, Minnesota.
Liaison Representatives: Jonathan Temte, MD, Madison, Wisconsin, Richard D. Clover, MD, Louisville, Kentucky, American Academy of Family Physicians; Margaret Rennels, MD, Baltimore, Maryland, Carol Baker, MD, Houston, Texas, American Academy of Pediatrics; Andrea Gelzer, MD, Hartford, Connecticut, America's Health Insurance Plans; James C. Turner, MD, Charlottesville, Virginia, American College Health Association; Stanley Gall, MD, Louisville, Kentucky, American College of Obstetricians and Gynecologists; Kathleen M. Neuzil, MD, Seattle, Washington, American College of Physicians; Litjen Tan, PhD, Chicago, Illinois, American Medical Association; Stephan L. Foster, PharmD, Memphis, Tennessee, American Pharmacists Association; W. Paul McKinney, MD, Louisville, Kentucky, Association of Teachers of Preventive Medicine; Clement Lewin, PhD, Orange, Connecticut, Biotechnology Industry Organization; Monika Naus, MD, Vancouver, British Columbia, Canada, Canadian National Advisory Committee on Immunization; Steve Gordon, MD, Cleveland, Ohio, Healthcare Infection Control Practices Advisory Committee, Samuel L. Katz, MD, Durham, North Carolina, and William Schaffner, MD, Nashville, Tennessee, Infectious Diseases Society of America; David M. Salisbury, MD, London, United Kingdom, London Department of Health; Nancy Bennett, MD, Rochester, New York, National Association of County and City Health Officials; David A. Neumann, PhD, Alexandria, Virginia, National Coalition for Adult Immunization; Romeo Rodriguez, Mexico City, Mexico, National Immunization Council and Child Health Program; Dennis A. Brooks, MD, Baltimore, Maryland, National Medical Association; Charles Helms, MD, Iowa City, Iowa, National Vaccine Advisory Committee; Amy B. Middleman, MD, Houston, Texas, Society for Adolescent Medicine; Damian A. Braga, MBA, Swiftwater, Pennsylvania, Peter Paradiso, PhD, Collegeville, Pennsylvania, Pharmaceutical Research and Manufacturers of America.
Preventing Tetanus, Diphtheria, and
Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced
Diphtheria Toxoid and Acellular Pertussis Vaccines: Recommendations
of the Advisory Committee on Immunization Practices (ACIP)
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.**Questions or messages regarding errors in formatting should be addressed to email@example.com.
Date last reviewed: 3/9/2006